Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.
Oncologist
; 24(6): e232-e240, 2019 06.
Article
in En
| MEDLINE
| ID: mdl-30413667
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Tubulin Modulators
/
Furans
/
Ketones
/
Neoplasm Recurrence, Local
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Oncologist
Journal subject:
NEOPLASIAS
Year:
2019
Type:
Article
Affiliation country:
Italy